ArticleInnere Medizin (Heidelberg, Germany)2026
[Biobanking in internal medicine : Structures, opportunities and cultural responsibility].
Article in Innere Medizin (Heidelberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Internal medicine is a medical discipline characterized by a high degree of complexity and interdisciplinarity. The focus of current health challenges is the aim to understand common and rare diseases, such as diabetes mellitus, cardiovascular diseases, autoimmune diseases or malignancies, in terms of their multifactorial causes and biological heterogeneity. This poses enormous medical and economic tasks to the healthcare system. Internal medicine is characterized by a close integration of patient care, pathophysiological research and evidence-based treatment. To investigate disease mechanisms and to develop individualized prevention and treatment measures, modern research approaches from molecular medicine, omics technologies and digital innovations are available. Access to high-quality, well-characterized biosamples that are linked to clinical data is an essential prerequisite for scientific progress. This is where academic biobanks play a crucial role. They systematically collect biological specimens such as blood, plasma, DNA or tissue and link them to detailed clinical, biochemical, genetic, histopathological, imaging and lifestyle-related data. Biobanking has become established as a sustainable research infrastructure embedded in the scientific culture of internal medicine, supporting continuous knowledge derived from patient care and ensuring long-term usability.
Indexed as
Identifiers
41770330What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.